0001607062-18-000351.txt : 20181015
0001607062-18-000351.hdr.sgml : 20181015
20181015161817
ACCESSION NUMBER: 0001607062-18-000351
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181003
FILED AS OF DATE: 20181015
DATE AS OF CHANGE: 20181015
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ro Andrew
CENTRAL INDEX KEY: 0001755880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 181122406
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 416-364-2551
MAIL ADDRESS:
STREET 1: 10102 USA TODAY WAY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
ownership.xml
X0306
4
2018-10-03
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001755880
Ro Andrew
10102 USA TODAY WAY
MIRAMAR
FL
33025
1
1
0
0
SVP & Chief Investment Officer
Stock Option (right to buy)
2.23
2018-10-03
4
A
0
4500
0
A
2028-10-03
Common Stock
4500
4500
D
The option vests in three equal annual installments beginning on October 3, 2018.
/s/ Gary A Miller as Attorney in Fact
2018-10-15